Credent Connect N Care Ltd vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 29, 2026

Key Highlights

The Latest Trading Price of Credent Connect N Care Ltd is ₹ 375 as of 29 Oct 15:09 . The P/E Ratio of Credent Connect N Care Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Credent Connect N Care Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Credent Connect N Care Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of Credent Connect N Care Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of Credent Connect N Care Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Credent Connect N Care Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Credent Connect N Care Ltd

Credent Connect N Care Limited was originally incorporated as a Private Company under the name of 'Credent Cold Chain Logistics Private Limited' on June 25, 2015 with the Registrar of Companies, Delhi.
Thereafter, the name of the Company was changed to 'Credent Connect N Care Private Limited' vide certified dated May 10, 2024.
Further, pursuant to a Special Resolution passed by the shareholder, the Company converted from Private Limited into Public limited and name of the Company has changed from 'Credent Connect N Care Private Limited' to 'Credent Connect N Care Limited' dated October 28, 2025. The Company is a healthcare services provider engaged in delivering integrated logistics, workforce solutions, and technology-enabled support to healthcare institutions across India.
It provide complete operational and logistics services to diagnostic laboratories, In Vitro Diagnostics (IVD) companies, pharmaceutical companies, clinics, and other healthcare enterprises through end-to-end solutions.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of null and Transgene Biotek Ltd

Which company has a larger market capitalization, Credent Connect N Care Ltd or Transgene Biotek Ltd?

Market cap of Credent Connect N Care Ltd is 634 Cr while Market cap of Transgene Biotek Ltd is 17 Cr

What are the key factors driving the stock performance of Credent Connect N Care Ltd and Transgene Biotek Ltd?

The stock performance of Credent Connect N Care Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Credent Connect N Care Ltd and Transgene Biotek Ltd?

As of October 29, 2026, the Credent Connect N Care Ltd stock price is INR ₹348.45. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.36.

How do dividend payouts of Credent Connect N Care Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of Credent Connect N Care Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.